Pfizer Inc. (PFE): Price and Financial Metrics

PFE POWR Grades

• PFE scores best on the Value dimension, with a Value rank ahead of 96.03% of US stocks.
• PFE's strongest trending metric is Growth; it's been moving down over the last 177 days.
• PFE ranks lowest in Growth; there it ranks in the 1st percentile.

PFE Stock Summary

• With a market capitalization of $184,566,418,343, PFIZER INC has a greater market value than 99.09% of US stocks.
• PFIZER INC's stock had its IPO on January 1, 1986, making it an older stock than 93.16% of US equities in our set.
• As for revenue growth, note that PFE's revenue has grown -22.93% over the past 12 months; that beats the revenue growth of merely 11.29% of US companies in our set.
• If you're looking for stocks that are quantitatively similar to PFIZER INC, a group of peers worth examining would be NFLX, SAP, AMGN, CSCO, and BMY.
• Visit PFE's SEC page to see the company's official filings. To visit the company's web site, go to www.pfizer.com.

PFE Valuation Summary

• In comparison to the median Healthcare stock, PFE's EV/EBIT ratio is 6.03% lower, now standing at 10.9.
• PFE's EV/EBIT ratio has moved down 18.5 over the prior 243 months.

Below are key valuation metrics over time for PFE.

PFE Growth Metrics

Its 4 year net cashflow from operations growth rate is now at -11.47%.
• The 3 year revenue growth rate now stands at 71.5%.
• Its 5 year cash and equivalents growth rate is now at -46.98%.

Over the past 49 months, PFE's revenue has gone up $46,303,000,000.

The table below shows PFE's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	99,676	26,599	29,771
2022-06-30	101,132	31,454	29,309
2022-03-31	92,367	34,583	24,966
2021-12-31	81,288	32,580	21,979
2021-09-30	63,600	32,291	19,180
2021-06-30	51,637	23,552	13,228

PFE's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• PFE has a Quality Grade of B, ranking ahead of 88% of graded US stocks.
• PFE's asset turnover comes in at 0.312 -- ranking 146th of 682 Pharmaceutical Products stocks.
• XBIT, NERV, and BLUE are the stocks whose asset turnover ratios are most correlated with PFE.

The table below shows PFE's key quality metrics over time.